12 Health Care Stocks Moving In Monday's Pre-Market Session

LongbridgeAII'm LongbridgeAI, I can summarize articles.

In Monday's pre-market session, several healthcare stocks showed significant movement. Greenland Mines surged 108.1% to $5.93, while Cue Biopharma rose 32.25% to $49.0. Other gainers included DataMEDS AI, Scinai Immunotherapeutics, Lakewood-Amedex, and Invivyd. Conversely, IM Cannabis dropped 30.3% to $2.95, with Aligos Therapeutics, Intelligent Bio Solutions, BeyondSpring, Palatin Techs, and Telix Pharmaceuticals also declining.

Gainers

  • Greenland Mines (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market session. The market value of their outstanding shares is at $9.0 million.
  • Cue Biopharma (NASDAQ:CUE) stock moved upwards by 32.25% to $49.0. The company's market cap stands at $269.1 million.
  • DataMEDS AI (NASDAQ:MEDS) shares moved upwards by 12.76% to $4.24. The market value of their outstanding shares is at $12.0 million.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 11.53% to $1.74. The market value of their outstanding shares is at $1.0 million.
  • Lakewood-Amedex (NASDAQ:LABT) shares moved upwards by 11.05% to $2.21. The market value of their outstanding shares is at $4.7 million.
  • Invivyd (NASDAQ:IVVD) stock moved upwards by 10.73% to $0.84. The market value of their outstanding shares is at $222.5 million.

Losers

  • IM Cannabis (NASDAQ:IMCC) shares decreased by 30.3% to $2.95 during Monday's pre-market session. The company's market cap stands at $2.5 million.
  • Aligos Therapeutics (NASDAQ:ALGS) stock decreased by 15.08% to $4.45. The company's market cap stands at $32.7 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) stock decreased by 13.84% to $1.68. The company's market cap stands at $6.4 million.
  • BeyondSpring (NASDAQ:BYSI) stock declined by 13.05% to $0.65. The market value of their outstanding shares is at $30.8 million.
  • Palatin Techs (NASDAQ:PTN) shares decreased by 12.53% to $9.5. The market value of their outstanding shares is at $19.3 million.
  • Telix Pharmaceuticals (NASDAQ:TLX) stock decreased by 9.46% to $11.4. The market value of their outstanding shares is at $4.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Login to unlock1,010characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.